Product category:
Proteomics
News Release from: Proteome Systems
Edited by the Laboratorytalk Editorial
Team on 16 May 2003
First installation in Japan
Proteome Systems and IBM announce the first installation of its technology platform designed to accelerate proteomics research and biological discovery in Japan
Proteome Systems and IBM have announced the first Japanese installation of ProteomIQ into the newly launched Iberica-Kurume Translational Research Laboratories Developed by Proteome Systems and jointly marketed with IBM, ProteomIQ is a comprehensive technology platform designed to accelerate proteomics research and biological discovery
This article was originally published on Laboratorytalk on 21 Dec 2001 at 8.00am (UK)
Related stories
In-gel digest kits for protein sample preparation
Proteome Systems and Millipore announce the new Millipore Montage in-gel digest kits, the first kits introduced since the relationship between the firms was announced earlier this year
Next generation proteomics platform
Combination of separation technology, robotics, mass spectrometr,y and enterprise level computing delivers "comprehensive outcomes" through its ability to decipher proteomic complexity
Keith Williams, CEO, Proteome Systems, said, "This is an exciting moment for Proteome Systems.
This installation closely follows the implementation of ProteomIQ into Charles River Proteomics Services in Worcester, Massachusetts.
We are delighted that ProteomIQ has been chosen as the proteomics technology platform to drive this new initiative of Iberica and Kurume University in pharmacoproteomics and pharmacokinetics.
Further reading
"Chemical Printing" technology announced
Proteome Systems announced today the first results of its Chemical Inkjet Printing (ChIP) program in the prestigious journal, Molecular and Cellular Proteomics.
New generation intelligent electrophoresis
Systems give proteomics researchers easy access to a new level of protein separation and array solutions which will maximise the output from mass spectrometry analysis
Analysis of protein expression data
Tools will bring a deeper level of analysis to accelerate the identification of proteins and their modifications that are scientifically and commercially important
A defining feature of ProteomIQ is its broad application and scalability, and this installation confirms ProteomIQ as a solution for drug discovery and development as well as large contract research organisations.
The modular design of ProteomIQ allows users to add analytical instrumentation, compute power and new technology at will, to increase research capacity as required." Kohichi Kajitani, life sciences manager, IBM Japan, said, "Proteomics is an increasingly important contributor to new drug development and is a field where IBM is committed to investing in product innovation and working with world-class partners like Proteome Systems.
The IBM infrastructure in the Iberica-Kurume Translational Research Laboratories will provide a robust and scalable capacity to store, process and analyse massive quantities of proteomic data.
Proteome Systems's immense breadth and depth of knowledge in proteomics, embodied in its ProteomIQ integrated platform, will enable researchers in the Iberica-Kurume Translational Research Laboratories to successfully address their research problems in pharmacoproteomics and pharmacokinetics." The ProteomIQ platform integrates award-winning technology to deliver a high resolution solution to the complexities of proteomics.
It includes Proteome Systems newly released IsoelectrIQ2 and ElectrophoretIQ3 protein separation technology and the Xcise gel processing robot developed in partnership with Shimadzu-Biotech.
The Xcise was recently awarded one of the Top Ten new products for 2002 by the Nikkan Kogyo Shimbun, Japan's premier business publication.
ProteomIQ also integrates the Shimadzu-Biotech Axima CFR mass spectrometer, which embodies Nobel-Prize winning technology from Shimadzu Corporation's Koichi Tanaka.
This instrumentation works seamlessly with an IT infrastructure that combines Proteome Systems's web-based BioinformatIQ software with IBM enterprise-level DB2 universal database, Tivoli storage and access management software, pSeries servers and scalable storage, to make ProteomIQ a powerful platform enabling high throughput proteomics.
Toshi Ohashi, CEO of Proteome Systems Japan, said, "This first installation of ProteomIQ in Japan marks an important milestone for Proteome Systems.
The integration, cross-platform validation and training provided with ProteomIQ will help researchers in the Iberica-Kurume Translational Research Laboratories to quickly adopt proteomics and successfully apply the technology to their investigations on drug effects and metabolism.".
• Proteome Systems: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
